Veri Medtech Holdings Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2011	FY 2010
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '11 Dec 31, 2011	Dec '10 Dec 31, 2010
Net Income	-2.32	-0.41	3.53	-0.35	-0.04
Depreciation & Amortization	0.11	0.1	0.03	0	-
Stock-Based Compensation	2.38	-	-	-	-
Provision & Write-off of Bad Debts	0	-	-	-	-
Other Operating Activities	0	-	-	-0	-
Change in Accounts Receivable	0.01	0.01	-0.02	0	0.01
Change in Inventory	-	-	-	-0	-0.01
Change in Accounts Payable	0.13	0.37	-0.05	0	0
Change in Unearned Revenue	0.03	-0.04	-0.01	-	-
Change in Other Net Operating Assets	-0.03	0.03	-0.07	-0	0.04
Operating Cash Flow	0.32	0.06	3.41	-0.34	0.01
Operating Cash Flow Growth	476.22%	-98.38%	-	-	-96.48%
Capital Expenditures	-0	-0	-0.06	-	-
Sale (Purchase) of Real Estate	-	-	-	0.31	-
Investment in Securities	-	-	-	-0.28	-0.53
Investing Cash Flow	-0	-0	-0.06	0.03	-0.53
Short-Term Debt Issued	0.79	0.1	0.03	-	-
Long-Term Debt Issued	-	-	-	-	0.01
Total Debt Issued	0.79	0.1	0.03	-	0.01
Short-Term Debt Repaid	-0.07	-0.1	-0.03	-	-
Long-Term Debt Repaid	-1.05	-0.62	-0.55	-0.18	-
Total Debt Repaid	-1.12	-0.71	-0.58	-0.18	-
Net Debt Issued (Repaid)	-0.33	-0.62	-0.55	-0.18	0.01
Issuance of Common Stock	-	0.55	0	0.5	0.52
Other Financing Activities	-	-	-2.91	-	-
Financing Cash Flow	-0.33	-0.07	-3.46	0.32	0.53
Net Cash Flow	-0.02	-0.01	-0.1	0.01	0.01
Free Cash Flow	0.32	0.05	3.35	-0.34	0.01
Free Cash Flow Growth	495.17%	-98.42%	-	-	-96.48%
Free Cash Flow Margin	2.92%	0.32%	15.14%	-525.76%	10.93%
Free Cash Flow Per Share	0.02	0.01	0.33	-0.18	0.01
Cash Interest Paid	-	0.11	0.1	-	-
Levered Free Cash Flow	-1.09	0.3	-	-0.02	-
Unlevered Free Cash Flow	-1.04	0.37	-	-0.02	-
Change in Working Capital	0.14	0.36	-0.15	0.01	0.04

Source: S&P Global Market Intelligence. Standard template. Financial Sources.